(Q71612666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

T Soulis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

M E Cooper

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

D Vranes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

R Bucala

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

G Jerums

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

English

0 references

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

627-634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1996.358

19 October 2019

exact match

0 references

cites work

Glycation of crystallins in lenses from aging and diabetic individuals

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Enzymatic determination of glucose and fructose simultaneously

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Validation in awake rats of a tail-cuff method for measuring systolic pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Antihypertensive therapy in a model combining spontaneous hypertension with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Determination of hydroxyproline

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

A technique to reduce fixation artifacts to kidney proximal tubules

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Determination of membrane thickness distribution from orthogonal intercepts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Role of oxidative stress in development of complications in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Early glycosylation products induce glomerular hyperfiltration in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Development of glomerular lesions in experimental long-term diabetes in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Effects of dietary protein content in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.358

7 January 2021

Identifiers

DOI

10.1038/KI.1996.358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8840295%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference